| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/106286060301800205 Analysis of a Large Cohort of Health Maintenance Organization Patients With Congestive Heart FailureHighmark Blue Cross Blue Shield, Pittsburgh, PA, patty.gladowski{at}highmark.com
Highmark Blue Cross Blue Shield, Pittsburgh, PA
Highmark Blue Cross Blue Shield, Pittsburgh, PA
Clinical Outcomes & Performance, Highmark Blue Cross Blue Shield, Pittsburgh, PA
Highmark Blue Cross Blue Shield, Pitts-burgh, PA The aim of this article was to measure guideline compliance in the care of health plan members diagnosed with congestive heart failure (CHF). Chart review was conducted on members with a discharge diagnosis of CHF (n = 2697). Information was entered onto a scannable form designed by the health plan, which was coupled to an optical character recognition reader and entered into a database. Eighty-four percent of the patients had an ejection fraction (EF) measured. An angiotensin-converting enzyme inhibitor was prescribed to 72% of patients with an EF less than 40%. Comorbidities and other measures were evaluated and based on guideline recommendations. Most of the CHF patients in this health plan are being treated appropriately during posthospitalization for CHF. The use of a novel, cost-effective method for data collection resulted in the rapid acquisition of clinical data for analysis.
Key Words: American College of Cardiology/American Heart Association Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult angiotensin 2 receptor blocker angiotensin-converting enzyme inhibitor Centers for Medicare and Medicaid Services congestive heart failure diastolic dysfunction ejection fraction Highmark Blue Cross Blue Shield systolic dysfunction Teleform software
|